Asan Medical Center
Seoul, 138-736, South Korea
NCT Number: NCT01897181
The purpose of this study is to evaluate the central auditory processing in patients with bilateral sensorineural hearing loss and to observe the change of the central auditory processing ability after using hearing aids.
Looking for future studies?
Notify Me45 year and older
All sexes
Interventional
Not applicable
Seoul, 138-736, South Korea
Screening for recruiting
Dividing into "Hearing aids" group and "No hearing aids" group
Audiologic test
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Using hearing aids for 12 months
Time frame: at screening and 6 months after starting hearing aids use
HINT measures a person's ability to hear speech in quiet and in noise. In the test, the patient is required to repeat sentences both in a quiet environment and with competing noise being presented from different directions.
Time frame: at screening, 1, 3, 6, 9, and 12 months after starting hearing aids use
The central auditory processing disorder test is composed of three subtests; duration pattern test, frequency pattern test and dichotic words test. The patient is required to discriminate long duration sound from short one and high frequency sound from low one, and to repeat two words that are given simultaneously.
Time frame: baseline, 3, 9 and 12 months
Jong Woo Chung
Other
Evaluation of the Central Auditory Processing in Patients (Elder Than 45 Years Old) With Bilateral Sensorineural Hearing Loss and the Change of the Central Auditory Processing Ability by the Use of Hearing Aids (CAPHA)
Acronym: CAPHA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02204618
Auditory Processing Disorder, Central, Communication Disorders
Toulouse, Midi-Pyrénées, France
View Trial DetailsNCT06970444
Auditory Diseases, Central, Auditory Perceptual Disorders
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT02889107
Auditory Processing Disorder, Central, Brain Diseases
London, United Kingdom
View Trial DetailsNCT06026124
Communication Disorders, Developmental Language Disorder
Indianapolis, Indiana, United States
View Trial Details